Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5194521
Max Phase: Preclinical
Molecular Formula: C40H58N8O10S2
Molecular Weight: 875.08
Associated Items:
ID: ALA5194521
Max Phase: Preclinical
Molecular Formula: C40H58N8O10S2
Molecular Weight: 875.08
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CSCc2cccc(n2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C40H58N8O10S2/c1-21(2)13-29-36(53)42-23(5)34(51)48-33(39(56)47-32(16-49)40(57)58)20-60-18-26-8-6-7-25(43-26)17-59-19-28(41)35(52)44-30(14-22(3)4)37(54)46-31(38(55)45-29)15-24-9-11-27(50)12-10-24/h6-12,21-23,28-33,49-50H,13-20,41H2,1-5H3,(H,42,53)(H,44,52)(H,45,55)(H,46,54)(H,47,56)(H,48,51)(H,57,58)/t23-,28-,29-,30-,31-,32-,33-/m0/s1
Standard InChI Key: KYNIZYCKZMOXEJ-RKNQSKIKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 875.08 | Molecular Weight (Monoisotopic): 874.3717 | AlogP: -0.06 | #Rotatable Bonds: 10 |
Polar Surface Area: 291.27 | Molecular Species: ACID | HBA: 13 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.47 | CX Basic pKa: 7.75 | CX LogP: -2.58 | CX LogD: -2.73 |
Aromatic Rings: 2 | Heavy Atoms: 60 | QED Weighted: 0.15 | Np Likeness Score: 0.72 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):